New drug Epidiolex by GW Pharmaceuticals gets FDA cinical trial approval for pediatric epilepsy
GW Pharmaceuticals; the company responsible for manufacturing Sativex, the cannabis extract in a spray bottle marketed for MS spasticity and neuropathic pain patients – have not tried to keep it